30
Oct
2011
Posted in I - Series B, Q - 3Q11, R - WEST, X - Device (Neuromodulation), XX - CA
Nevro (Menlo Park, CA) a clinical-stage medical device company focused on neuromodulation for the relief of chronic pain, closed a $58M Series B financing. Participants include Johnson & Johnson Development Corp, Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, MPM Capital and Three Arch Partners.
01
Sep
2011
Posted in I - Series A, Q - 2Q11, R - WEST, X - Device (Cardiology), X - Device (Neuromodulation), XX - CA
Jan Medical (Mountain View, CA) a development-stage medical device company focused on a brain sensing device for the timely determination of ischemic stroke, closed a $3.1M Series A financing. Participants include Brainlab.
The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals [...]
01
Aug
2011
Posted in I - Series E, Q - 2Q11, R - NORTH EAST, X - Device (Neuromod), X - Device (Neuromodulation), XX - PA
Neuronetics (Malvern, PA) a commercial-stage medical device company focused on pulsed magnetic field stimulation for non-invasive, non-systemic treatment of depression, closed a $30M Series E financing. Participants include Polaris Venture Partners, Pfizer Venture Investments, Investor Growth Capital, New Leaf Venture Partners, Interwest Partners, Three Arch Partners, Quaker BioVentures and Onset Ventures.
27
Oct
2009
Posted in I - Series D, Q - 3Q09, R - NORTH EAST, X - Device (Neuromodulation), XX - PA
Neuronetics (Malvern, PA) a commercial-stage medical device company focused on transcranial magnetic neuromodulation for psychiatric and neurological disorders, closed a $36M Series D financing. Participants include New Leaf Venture Partners, Investor Growth Capital, Quaker BioVentures, Three Arch Partners, Onset Ventures, Interwest Partners and KBL Healthcare Ventures.